P1332: PROMISING OUTCOME OF PATIENTS OLDER THAN 70 YEARS WHO UNDERWENT PERIPHERAL BLOOD HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OR HIGH RISK MYELODYSPLASTIC SYNDROME

Benzer Materyaller

• P1332: PROMISING OUTCOME OF PATIENTS OLDER THAN 70 YEARS WHO UNDERWENT PERIPHERAL BLOOD HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OR HIGH RISK MYELODYSPLASTIC SYNDROME
  Yazar:: S. Harbi, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-06-01)
• P1329: POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) VERSUS ANTITHYMOCYTE GLOBULIN (ATG) AS GVHD PROPHYLAXIS FOR MATCHED UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION.
  Yazar:: F. Dachy, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-06-01)
• Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy
  Yazar:: Scott R. Solomon, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-10-01)
• Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation
  Yazar:: Mustafa A. Hyder, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-05-01)
• Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide
  Yazar:: Scott R. Solomon, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-01-01)